KL and type 2 diabetes mellitus: In particular, Klotho could act as an inhibitor of IGF-1R signaling to improve hepatic glucolipid homeostasis and lipid accumulation in Type 2 diabetes (T2D) [26], that prompted us to determine whether IGF-1R acted as a regulator linking Klotho to RAC1.